Inventor

WUSTROW DAVID JUERGEN

US38 patents

⚠️ This page may combine multiple inventors who share the name “WUSTROW DAVID JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WUSTROW DAVID JUERGEN

WARNER LAMBERT CO

Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

Branched alkyl pyrrolidine-3-carboxylic acids

Mono-and disubstituted 3-propyl gamma-aminobutyric acids

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases

Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

Alpha 2 delta ligands for post-traumatic stress disorder

Amino heterocycles useful as pharmaceutical agents

Method of treating noninflammatory cartilage damage

Method of treating tinnitus

Method of treating tinnitus

Substituted gamma aminobutyric acids as pharmaceutical agents

Dopamine D4 receptor antagonists

Amino acids with affinity for the α-2-delta-protein

Dopamine D4 receptor antagonists

Method of treating noninflammatory cartilage damage

Tetrazole and oxadiazolone substituted β-amino acid derivatives

Process for R (+) 1,2,3,6-tetrahydro-4-phenyl-1- (3-phenyl-3-cyclohexen-1-yl)methyl!pyridine, a central nervous system agent

Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

Cycloproply β-amino acid derivatives

Coumarin dopamine D4 receptor antagonists

PFIZER

4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders

1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders

Alpha2delta ligands for fibromyalgia and other disorders

Gamma amino butyric and acid analogs

Amines as pharmaceutical agents

Method of treatment for sexual dysfunction

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases

Prodrugs of amino acids with affinity for the α2δ-protein

Amino acids with affinity for the α2δ-protein

RAPT THERAPEUTICS INC

Chemokine receptor modulators and uses thereof

Chemokine receptor modulators and uses thereof

Chemokine receptor modulators and uses thereof

Chemokine receptor modulators and uses thereof

Chemokine receptor modulators and uses thereof

Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof

FLX BIO INC

Chemokine receptor modulators and uses thereof

Chemokine receptor modulators and uses thereof

Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof